Page results
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Read more about the Halcyon linear accelerator, aimed at making cancer treatment faster, more comfortable, and more precise for patients.
-
Doctors at UCLH and University College London (UCL) have developed a digital decision-making aid, MENO.pause, to help clinicians manage menopause symptoms in the best way for individual patients’ health conditions.
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
File results
-
FOI/2023/0604 - Patient flow system
-
FOI/2023/0609 - Companies that currently have contracts at UCLH
-
FOI/2023/0613 - Treatment for Melanoma
-
FOI/2023/0615 - Wayfinding strategy
-
FOI/2023/0617 - Neonatal unit CCTV
-
FOI/2023/0623 - BMA rate card rates
-
FOI/2023/0635 - Redundancy consultation
-
FOI/2023/0637 - Trust’s policy/eligibility for treatment at Eastman Dental Hospital
-
FOI/2023/0647 - Radiation Protection Supervisor
-
FOI/2023/0648 - Robotic Process Automation (RPA)